Harold Gruber, DPM
Podiatrist · Wilmington, DENPI 1386734143
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,782 of the $9,828 with a category attached, or 79.2%. 7 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 36.9% of the total. Reporting peaked in 2023 at $3,174 and has fallen 58.2% since, to $1,326 in 2025. Among podiatrist clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $75.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$4K
- Smith+Nephew$3K
- Ossio Inc$2K
- Osteomed LLC$881
- Stryker$368
- Medtronic$93
- plus $88 from 1 others
What the payments were for
- Travel & lodging$1,52516%
- Food & beverage$7,78279%
- Education$5215%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 40 | $3,625 |
| Smith+Nephew | 53 | $2,935 |
| Ossio Inc | 1 | $1,839 |
| Osteomed LLC | 26 | $881 |
| Stryker | 7 | $368 |
| Medtronic | 1 | $93 |
| Acumed LLC | 2 | $88 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,631
- GRAFIX PL$402
- Grafix$293
- STRAVIX MESH$253
- PROSTEP MICA$161
- Oasis$149
- Stravix$149
- STRAVIX PL$149
How this compares
$9,828 in reported general payments places this provider in the 95th percentile of 37 podiatrist providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 32 | $187 |
| Silver Sulfadiazine | 20 | $90 |
| Meloxicam | 29 | $57 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Wilmington
- Lahari MadulapallyWilmington$9K
- Brian McDermottWilmington$7K
- Lesly RobinsonWilmington$3K
- Sandra HudakWilmington$2K
- Anmol BurmiWilmington$2K
- Luis GarciaWilmington$1K
- Lori LarueWilmington$501
- Christopher SavageWilmington$473
- Michael HenryWilmington$316
- Michael HaagWilmington$273
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.